The stocks of CRUS have been given a rating of hold, which has been reiterated by several analysts working at Oppenheimer. The report was sent out to quite a few investors, as the brokerage also estimated the Q3 earnings of the company at $1.73, the Q4 earnings at around $0.55 EPS, and the FY 2021 earnings at an EPS of $3.64.
The Quarterly Earnings of CRUS
There have been quite a few research equities that have commented on the stocks of this company. KeyCorp has increased the stocks of CRUS from a rating of sector weight to a rating of overweight, along with a price target of $100. This was published in a research report that was published on the 6th of January.
Zacks Investment Research has decreased the rating of buy with a rating of hold, along with a price target of $73 on the stocks of the firm. Craig Hallum has also increased the price target of the company from $70 to $80, along with a rating of buy. Barclays has increased the price target of the company from a sum of $70 to $90, along with a rating of equal weight in a Friday research report. In the end, Cowen joined in with a price target of $95 on the stocks of the firm.
Five of the research analysts have already provided the stocks with a rating of hold, while seven of them gave it a rating of buy. Currently, the stocks of CRUS have a rating of buy, with a price target of $87.67.
The stocks of CRUS traded at $91.52 last Tuesday. The year low of the company is $47.04, with a year high of around $92.88. The market cap of the firm is $5.31 billion, with a PE ratio of around 35.34.
